Novel Dry Powder Formulation and Delivery Systems

Dear Colleagues,

The 17 sustainable development goals (SDGs) from the 2030 Agenda for Sustainable Development, adopted by the UN Member States in 2015, express a plan of action for people, planet, and prosperity. Several of these goals highlight the promotion of well-being for all, reducing inequality within and among countries, promoting inclusive and sustainable industrialization, and fostering innovation. Dry powder formulations offer controlled drug release, reduced local and systemic toxicities, patient compliance, and storage stability by avoiding cold distribution and supply chains (known as one of the biggest challenges related to the current mRNA-based SARS-CoV-2019 vaccines), with increasing industrial implementation. Therefore, this Special Issue aims to highlight the most recent advances in novel dry powder formulations, delivery platforms, and controlled release systems of small molecule drugs, vaccines, and biopharmaceuticals. This Special Issue will also address green, continuous, and combined processes for particle engineering, from fundamental to application-based studies, and the challenges faced in industrial implementation. Given the relevance behind the research in this field, it is my pleasure to invite you to submit, in this Special Issue, your original research articles, reviews and together contribute to a sustainable and inclusive world.

Prof. Dr. Renata Adami
Prof. Dr. Teresa Casimiro
Dr. Clarinda Costa
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.